Citation Impact
Citing Papers
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
2009
Cancer statistics, 2024
2024 Standout
The history of cancer epigenetics
2004 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
The biology of ovarian cancer: new opportunities for translation
2009
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
1999
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ovarian cancer
2014 Standout
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
2001
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Gestational trophoblastic disease
2010 Standout
Quercetin enhances transforming growth factor β1, secretion by human ovarian cancer cells
1994
Transforming growth factor-β1 expression during placental development
1991
Microsatellite analysis at 1p36.3 in malignant melanoma of the skin
2003
SWI/SNF nucleosome remodellers and cancer
2011 Standout
STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer
2013
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
2008
Cancer of the Ovary
1993
Selecting protein tyrosine phosphatases as drug targets
2002
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors
2001
The two faces of PTP1B in cancer
2009
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Precursors to pelvic serous carcinoma and their clinical implications
2009
Luminal and Glandular Endometrial Epithelium Express Integrins Differentially Throughout the Menstrual Cycle: Implications for Implantation, Contraception, and Infertility
1996
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Effects of multiagent chemotherapy and independent risk factors in the treatment of high‐risk GTT —25 years experiences of KRI‐TRD
1998
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
1995 Standout
Current management of gestational trophoblastic diseases
2008
Polycystic Ovary Syndrome
2005 Standout
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
2012 Standout
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis
2007 Standout
PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells
2008 StandoutNobel
MicroRNA signatures in human cancers
2006 Standout
Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone
1998
Protein Tyrosine Phosphatases in the Human Genome
2004 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Polycystic ovary syndrome and cancer
2001
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
2012 Standout
Time of Implantation of the Conceptus and Loss of Pregnancy
1999 Standout
Genomic and functional evidence for an ARID1A tumor suppressor role
2007
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Ovarian Cancer Development and Metastasis
2010
Ovarian cancer: Epidemiology, biology, and prognostic factors
2000
Cancer of the Ovary
2004 Standout
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.
2000
Multicomponent Reactions with Isocyanides
2000 Standout
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
1993
Synthesis and Function of 3-Phosphorylated Inositol Lipids
2001 Standout
Hereditary gynaecological malignancies: advances in screening and treatment
2012
Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer.
2000
Targeted nanoparticles for detecting and treating cancer
2006
Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review
2009
CA125 in Ovarian Cancer
2007
Protein Tyrosine Phosphatases: Structure and Function, Substrate Specificity, and Inhibitor Development
2002
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
Chemotherapy for Advanced Epithelial Ovarian Cancer
1992
Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
2006
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
2008
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Natural Products as Sources of New Drugs over the Last 25 Years
2007 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Allelic imbalance and mutations of thePTEN gene in ovarian cancer
2000
A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression
2017 StandoutNobel
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
2003
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Challenges in the development of magnetic particles for therapeutic applications
2008
New Therapies for Ovarian Cancer
1992
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer
2007
Immunosuppressive Factors: Role in Cancer Development and Progression
1998
Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries
2023
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Endometrial Carcinoma
1996
Synthesis of Nh-acyl-α-aminoamides on rink resin: Inhibitors of the hematopoietic protein tyrosine phosphatase (HePTP)
1995
Down-regulation of Integrin α2 Surface Expression by Mutant Epidermal Growth Factor Receptor (EGFRvIII) Induces Aberrant Cell Spreading and Focal Adhesion Formation
2005
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Works of A. Berchuck being referenced
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers
2000
Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer
1992
Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation
1992
Phase I/II trial of intravenous Doxil® and whole abdomen hyperthermia in patients with refractory ovarian cancer
2005
Allele Loss on Chromosome 1p36 in Epithelial Ovarian Cancers
2001
Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆
2007
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma
2001
Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas
1994
Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma
1993
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
1990
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis
2006
Mutation of thePTENTumor Suppressor Gene Is Not a Feature of Ovarian Cancers
1998
Use of trastuzumab in the treatment of metastatic endometrial cancer
2006
Relationship between race and interval to treatment in endometrial cancer
1995
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis
2006
Distribution of integrin cell adhesion molecules in endometrial cancer.
1995
The role of peptide growth factors in epithelial ovarian cancer.
1990
Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease
1994